Tenon Medical Overview
Latest ROE for Tenon Medical: 783.99% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow783.99%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Tenon Medical (TNON) currently reports a ROE of 783.99%. That is above the sector sector average of 11.64%. Use the charts on this page to explore Tenon Medical's ROE history and peer comparisons.
Tenon Medical's ROE of 783.99% is higher than the its sector sector average of 11.64%. That is roughly 6637.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Tenon Medical's current 783.99% should be judged against industry norms (sector average: 11.64%) and against TNON's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 783.99%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for Tenon Medical, and consider following TNON for alerts when major investors trade the stock.
